phorbolol myristate acetate has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denning, G; Doering, CB; Johnston, JM; Le Doux, JM; Moot, R; Shields, J; Spencer, HT; Whitehead, D | 1 |
| Chandrika, G; Chugh, A; Natesh, K; Ranade, D; Shastry, P | 1 |
2 other study(ies) available for phorbolol myristate acetate and sirolimus
| Article | Year |
|---|---|
High-throughput screening identifies compounds that enhance lentiviral transduction.
Topics: Animals; Antigens, CD34; Camptothecin; Cell Line, Tumor; Colforsin; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; HEK293 Cells; Hematopoietic Stem Cells; High-Throughput Screening Assays; Humans; Lentivirus; Mice; NIH 3T3 Cells; Sirolimus; Tetradecanoylphorbol Acetate; Transduction, Genetic; U937 Cells | 2014 |
Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Fibronectins; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Naphthyridines; Neoplasm Recurrence, Local; Neural Stem Cells; Oncostatin M; Phosphatidylinositol 3-Kinases; Signal Transduction; Sirolimus; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate; TOR Serine-Threonine Kinases; Vimentin | 2017 |